NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

What was recalled

The Consumer Product Safety Commission (CPSC) has issued a recall for a specific batch of NumbSkin pain relief cream manufactured by SeeNext Venture. This action, announced on March 18, 2020, targets a topical anesthetic product designed to provide temporary relief from minor aches and pains associated with arthritis, muscle soreness, and backache. While the product itself is a standard over-the-counter remedy, the recall focuses on a critical manufacturing oversight regarding its packaging rather than the chemical composition of the cream itself. The affected items are 30-gram tubes of NumbSkin cream, which were packaged in distinctive white tubes with blue accents. The brand name "NumbSkin" is clearly printed on the exterior of each tube to identify the product.

To help consumers determine if they possess a recalled unit, it is essential to look closely at the physical details of the packaging. The specific lot number for this recall is 9238. This batch number is printed directly on the outer product packaging box. Furthermore, the individual tube itself features an embossed date code located on its thin end. These codes follow a MM/YYYY format and range from October 2019 through September 2020 (10/2019 through 09/2020). If your tube does not match this lot number or date range, it is likely not part of this specific recall action. However, given the potential risks involved, verifying these codes is a necessary step for safety.

The product was primarily sold through Amazon, where it reached a wide audience of consumers seeking pain relief solutions. While the CPSC alert does not specify the exact total number of units distributed or sold during this period, the involvement of a major e-commerce platform suggests a significant volume was in circulation. Amazon has taken proactive steps by contacting all known purchasers directly to inform them of the issue. The recall stems from a failure to meet the requirements set forth by the Poison Prevention Packaging Act, which mandates that certain hazardous household substances be packaged in child-resistant containers to prevent accidental ingestion or exposure by young children.

SeeNext Venture, the company responsible for the brand, initiated this voluntary recall after identifying that the packaging used for these specific lots did not adequately protect against access by children. The product contains 5% lidocaine, a potent topical anesthetic. While effective for adults when used as directed, lidocaine can be dangerous if ingested or absorbed in large quantities by young children who might mistake the tube for a toy or candy. The recall underscores the importance of compliant packaging standards in consumer health products, ensuring that even well-intentioned remedies do not become inadvertent hazards to families with young children.

The hazard, explained

To understand why this specific recall is necessary, we first need to look at the relationship between the product’s chemical ingredients and its physical packaging. The NumbSkin pain relief cream in question contains 5% lidocaine. Lidocaine is a topical anesthetic, which means it works by temporarily blocking nerve signals in a localized area of the body to prevent pain. While this mechanism is highly effective for adults managing minor cuts, burns, or insect bites when used exactly as directed, the chemical itself is potent and can be dangerous if it enters the body through unintended pathways.

The core issue with this recall is not that the cream is chemically defective or expired, but that its container fails to meet a critical safety standard. Under the Poison Prevention Packaging Act, certain hazardous household substances must be sold in special child-resistant containers. These are not standard caps; they are engineered with complex mechanisms—often requiring simultaneous pushing and turning—that are difficult for young children to manipulate but manageable for most adults. The NumbSkin tubes recalled by SeeNext Venture do not have this specialized packaging. This means that a toddler or young child, who might be drawn to the bright colors or curious about the texture of the tube, can easily open it with little to no effort.

When the packaging barrier is removed, the risk shifts from simple irritation to potential systemic poisoning. The hazard arises in two primary ways: ingestion and excessive absorption. If a child puts the cream on their skin and then touches their mouth, or directly ingests the substance, the lidocaine can enter the bloodstream rapidly. Because children have smaller body mass and developing metabolic systems, even a small amount of lidocaine that would be harmless to an adult can cause severe symptoms. These may include dizziness, confusion, seizures, difficulty breathing, or changes in heart rate.

Furthermore, because this is a topical anesthetic, it is designed to penetrate the skin. If a child applies it to a large area of their body or over sensitive mucous membranes (such as the inside of the mouth), the absorption rate can be much higher than intended for a targeted adult dose. This increases the concentration of the drug in the blood more quickly than the body can process it. The recall alert specifically highlights this risk, noting that the failure to meet child-resistant packaging requirements creates an unnecessary opportunity for young children to access a potent medication. While no incidents have been reported as of the recall date in March 2020, the potential for serious harm exists whenever a potent chemical agent is accessible to those who cannot understand or control its dosage.

Who is most at risk

The primary group at immediate and serious risk from this recall are young children, particularly those under the age of five. This specific hazard stems not from the ingredients themselves being inherently toxic in small, controlled doses, but from the failure of the packaging to prevent unsupervised access. The NumbSkin pain relief cream contains 5% lidocaine, a topical anesthetic that numbs the skin. While effective for adults managing minor pain or preparing for minor procedures, lidocaine becomes dangerous when ingested by small bodies or absorbed through the skin in large quantities because children lack the cognitive ability to recognize hazardous substances or resist curiosity. The core issue here is accessibility: because the packaging does not meet the Child Resistant Packaging (CRP) standards mandated by the Poison Prevention Packaging Act, a determined child can easily open the tube. Unlike standard safety caps that require a specific twisting-and-pushing motion difficult for small fingers to master, this defective packaging offers no physical barrier to entry, turning a common household item into an accidental poisoning vector.

It is also important to consider who might be using this product in a home where young children reside. Typically, these creams are purchased by parents, caregivers, or grandparents for managing teething pain, minor cuts, insect bites, or muscle soreness. These individuals are often tired, distracted, or rushing, which increases the likelihood of leaving the product within reach after use. The risk is compounded by the fact that the cream is applied to the skin, meaning it can be transferred from the caregiver’s hands to the child’s mouth if handwashing is not performed immediately and thoroughly after application. Even if the packaging had been compliant, the proximity of pain relief products to children creates a high-stakes environment where any lapse in attention can lead to exposure.

Elderly individuals or those with chronic pain conditions are also part of the user base for this product, as they often rely on topical numbing agents for joint pain, arthritis, or nerve discomfort. While they are not at risk of accidental poisoning from themselves, their use of the product creates a secondary risk if they share living spaces with grandchildren or other young visitors. Furthermore, elderly users may have reduced dexterity or vision, potentially making them less aware of the packaging defect or more likely to store the item in accessible locations like nightstands or bathroom counters where children can climb and reach. The combination of an adult user who may be less vigilant about child-proofing due to physical limitations, paired with a product that fails to secure itself, creates a perfect storm for accidental ingestion or dermal absorption by a vulnerable child.

Additionally, anyone with pets should be aware that while the recall focuses on human children, lidocaine can also be toxic to animals if licked off treated skin. Although not explicitly cited in the incident reports, this is a well-known general safety concern for topical anesthetics. Therefore, any household member who owns dogs or cats must treat this recalled item with extreme caution, ensuring it is stored so that no animal can access it, just as one would secure medications from young children.

How to tell if you have the recalled item

Identifying whether your tube of NumbSkin pain relief cream is part of this specific recall requires a careful inspection of the packaging itself. Because the issue stems from the lack of child-resistant safety features on the cap, you cannot rely solely on the product name or general appearance to determine if it is affected. Instead, you must verify two critical pieces of information: the lot number and the date code. If your tube does not match these specific identifiers, it is safe from this particular recall alert issued by SeeNext Venture.

First, examine the physical container closely. The recalled product is a topical anesthetic cream packaged in a white tube with blue accents or text. The brand name "NumbSkin" should be clearly printed on the side of the tube. This helps distinguish it from other pain relief creams you might have at home, but it does not confirm whether your specific item is unsafe. To do that, you need to look for the manufacturing details.

Turn the tube over and inspect the thin end (the crimped seal area). Here, you will find essential production data embossed directly into the plastic. You are looking for two distinct pieces of information printed in a MM/YYYY format. This date code represents the month and year of manufacture. The recalled items have a date code ranging from 10/2019 through 09/2020. If your tube shows a date outside this window, such as a date in early 2019 or late 2020, it is not part of this recall.

In addition to the date, you must check for the batch number. On the thin end of the tub, there should be a lot number embossed as 9238. This number is also printed on the outer product packaging box if you still have it. The combination of Lot 9238 AND a date code between October 2019 and September 2020 confirms your product is included in this recall. Without both of these identifiers, your product is not subject to this specific safety action.

If you are unsure where to look or cannot read the embossed text due to wear or lighting, remember that Amazon has been contacting all known purchasers directly regarding this recall. If you bought the cream through Amazon, check your order history and email for correspondence from the seller or platform. For those who purchased elsewhere, the visual inspection of the lot number and date code on the tube’s end remains the only definitive way to confirm if your item needs to be returned or disposed of.

What to do — step by step

Your refund, repair, or replacement options

When you discover that a product in your home has been recalled, the immediate concern is often how to resolve the issue without losing money or enduring unnecessary hassle. In this specific case involving NumbSkin pain relief cream, the manufacturer, SeeNext Venture, along with retail partners like Amazon, have established a clear and consumer-friendly remedy. It is important to understand that you are not expected to simply throw the product away immediately without guidance, nor are you left to navigate the process alone. The company has committed to providing a free replacement similar product that includes a properly child-resistant cap, which directly addresses the safety flaw identified in the original packaging.

The primary path to resolution is through direct contact with SeeNext Venture. They have set up dedicated channels to assist customers who need to dispose of the unsafe cream or arrange for its return. You can reach their support team by calling their toll-free number at 844-700-6862. These lines are open from 9 a.m. to 6 p.m. Pacific Time, Monday through Saturday, ensuring that you have ample opportunity during the week to speak with a representative. Alternatively, you may send an email to distributions@numbskin.com if you prefer written communication or wish to document your inquiry. For those who prefer digital self-service, you can visit www.numbskin.com and click on the “Recall” link located on the home page. This online portal is designed to streamline the process, allowing you to get instructions on how to safely dispose of the cream or return it for a replacement.

If you purchased this product through Amazon, there is an additional layer of support available to you. Amazon has stated that they are contacting all known purchasers directly. This means that if your order history matches the criteria for this recall, you may receive instructions from Amazon’s customer service team without needing to initiate the contact yourself. It is advisable to check your email inbox and your Amazon account notifications regularly for any updates regarding your specific order status.

The remedy provided here focuses on safety and satisfaction. By receiving a replacement with a child-resistant cap, you are not just getting another tube of cream; you are getting a version that meets the federal Poison Prevention Packaging Act requirements. This ensures that the lidocaine inside remains safely contained from young children who might otherwise access it. The process is designed to be free of charge for you, eliminating any financial burden associated with correcting this safety defect. Please remember to follow the specific disposal instructions given by SeeNext Venture or Amazon carefully to ensure the product does not pose a hazard during its removal from your home.

What can happen if you ignore it

When a product recall involves child-resistant packaging, the stakes are rarely about the product failing to work as intended; they are about the product becoming accessible to those who should not have it. In the case of the NumbSkin pain relief cream recalled by SeeNext Venture, ignoring the warning means leaving a concentrated topical anesthetic within easy reach of curious children. While the recall notice notes that no incidents have been reported at the time of this alert, the absence of reported injuries does not mean the risk is theoretical. It simply means that, so far, the worst-case scenario has been narrowly avoided by luck or vigilant parenting. Continuing to use a product without the required safety features relies entirely on hope rather than engineering.

The core danger lies in the active ingredient: lidocaine. This is not a mild herbal salve; it is a potent local anesthetic designed to numb nerve endings. For an adult, this is beneficial. For a young child, whose body mass is significantly smaller and whose metabolic systems are still developing, even a small amount of lidocaine can be toxic. If a child manages to open the tube because the cap lacks the necessary child-resistant mechanism, they may apply it to their skin or, more alarmingly, ingest it. The skin of infants and toddlers is more permeable than adult skin, meaning chemicals can enter the bloodstream faster and in higher concentrations. This bypasses many of the body’s natural defenses against toxins.

The consequences of such exposure can range from immediate physical distress to life-threatening systemic poisoning. Lidocaine toxicity affects the central nervous system and the heart. In mild cases, a child might experience drowsiness, confusion, or nausea. However, as the level of the drug in the blood rises, the risks escalate quickly. Severe poisoning can lead to seizures, irregular heart rhythms, difficulty breathing, and in extreme cases, coma or death. Because lidocaine works by blocking nerve signals, an overdose can essentially shut down the body’s ability to regulate vital functions correctly. This is not a reaction that one can simply "wait out" at home; it requires immediate medical intervention.

By ignoring the recall, you are also missing out on a free replacement that comes with proper safety safeguards. The manufacturer has acknowledged that the current packaging is insufficient and is providing units with child-resistant caps. Choosing to keep the non-compliant tube means you are essentially building a house of cards around your child’s safety. You would have to rely on perfect supervision every single time the product is used, stored, or handled. One moment of distraction, one forgotten latch, or one determined toddler can turn a routine pain relief treatment into a medical emergency. The recall remedy exists to remove that variable entirely, replacing uncertainty with a guaranteed layer of protection.

Staying safe: broader tips

While this specific recall highlights a packaging failure, it serves as a powerful reminder that safety often hinges on small details we might overlook in our daily routines. Lidocaine and other topical pain relievers are incredibly common household staples, found in everything from muscle rubs to first-aid kits. However, their accessibility makes them potential hazards if not handled with care. The most effective way to stay safe is to treat every medication and chemical product with the same respect you would give prescription drugs. This means never assuming that "over-the-counter" equals "safe for everyone," especially children.

One of the most critical habits you can build is consistent storage. Many accidents occur simply because a bottle was left out on a counter after use, within easy reach of a curious child. To prevent this, establish a designated "high and dry" spot for all medical supplies—ideally in a locked cabinet or on a high shelf that requires a step stool to reach. If your home does not have such storage, consider using safety latches on lower cabinets. Remember that children are imaginative; they may hide items in plain sight or mistake colorful packaging for candy. Securing these products out of immediate physical access is your first line of defense against accidental ingestion or skin exposure.

Furthermore, always read the label before every use, not just the first time. Packaging regulations change, and manufacturers update their formulas and safety warnings regularly. Look specifically for child-resistant caps, which are designed to require a combination of downward pressure and twisting to open—a motor skill most young children have not yet developed. If you ever receive a product that seems easier to open than expected, or if the cap feels loose, do not use it. Contact the manufacturer immediately, as this may indicate a manufacturing defect similar to the one addressed in this recall.

Finally, stay proactive about monitoring product safety in your home. Sign up for email alerts from the Consumer Product Safety Commission (CPSC) and the Food and Drug Administration (FDA). These agencies issue recalls frequently, and early notification can prevent harm before it happens. Regularly check your medicine cabinets and first-aid kits for expired or recalled items. By making these small checks a routine part of your household management, you create a safer environment for everyone, turning potential risks into managed routines.